These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8446265)

  • 1. Mucosal immunity in primary glomerulonephritis. III. Study of intestinal permeability.
    Rostoker G; Wirquin V; Terzidis H; Petit-Phar M; Chaumette MT; Delchier JC; Belghiti D; Lang P; Dubert JM; Meignan M
    Nephron; 1993; 63(3):286-90. PubMed ID: 8446265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular hyperpermeability in nephrotic edema.
    Rostoker G; Behar A; Lagrue G
    Nephron; 2000 Jul; 85(3):194-200. PubMed ID: 10867533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertoire to food and airborne antigens.
    Rostoker G; Petit-Phar M; Delprato S; Terzidis H; Lang P; Dubert JM; Weil B; Lagrue G
    Nephron; 1991; 59(4):561-6. PubMed ID: 1766494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of intestinal permeability in IgA mesangial nephritis and primary glomerulonephritis.
    Rostoker G; Wirquin V; Terzidis H; Chaumette MT; Lang P; Weil B
    Adv Exp Med Biol; 1995; 371B():839-41. PubMed ID: 7502909
    [No Abstract]   [Full Text] [Related]  

  • 5. [IgA and IgG antibodies to Chlamydia in IgA nephropathy as well as in mesangiocapillary and membranous glomerulonephritis].
    Nagy J; Sarov I; Sámik J; Trinn C; Kun L; Burger T; Sarov B
    Orv Hetil; 1989 Jul; 130(29):1527-30. PubMed ID: 2671859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunity in adult primary glomerulonephritis. I. Evaluation of salivary IgA subclasses and components.
    Rostoker G; Pech MA; Petit-Phar M; BenMaadi A; Cholin S; Lang P; Dubert JM; Weil B; Lagrue G
    Nephron; 1990; 54(1):42-6. PubMed ID: 2296344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis].
    Nagy J; Goshen E; Livne A; Sarov I; Shoenfeld Y
    Orv Hetil; 1991 Mar; 132(12):623-8. PubMed ID: 2011384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides?
    Rostoker G; Delchier JC; Chaumette MT
    Nephrol Dial Transplant; 2001 Mar; 16(3):513-7. PubMed ID: 11239024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing pattern of glomerulonephritis in Singapore over the past two decades.
    Woo KT; Chiang GS; Pall A; Tan PH; Lau YK; Chin YM
    Clin Nephrol; 1999 Aug; 52(2):96-102. PubMed ID: 10480220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of IGA antigliadin antibodies during primary glomerulonephritis with mesangial IGA deposits].
    Rostoker G; Delprato S; Benmaadi A; Petit-Phar M; Andre C; Laurent J; Lang P; Weil B; Lagrue G
    Ann Med Interne (Paris); 1989; 140(7):571-4. PubMed ID: 2610450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability in IgA nephropathy.
    Jenkins DA; Bell GM; Ferguson A; Lambie AT
    Nephron; 1988; 50(4):390. PubMed ID: 3237284
    [No Abstract]   [Full Text] [Related]  

  • 13. An increase in circulating IgA antibodies to gliadin in IgA mesangial glomerulonephritis.
    Laurent J; Branellec A; Heslan JM; Rostoker G; Bruneau C; André C; Intrator L; Lagrue G
    Am J Nephrol; 1987; 7(3):178-83. PubMed ID: 3631148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fibronectin in immune glomerulonephritis.
    Altunkova I; Minkova V; Belovezhdov N
    Nephron; 1993; 63(4):438-44. PubMed ID: 8459880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis.
    Rostoker G; Terzidis H; Petit-Phar M; Meillet D; Lang P; Dubert JM; Lagrue G; Weil B
    Clin Exp Immunol; 1992 Nov; 90(2):305-11. PubMed ID: 1424290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?
    Davenport A; Maciver AG; Mackenzie JC
    Nephrol Dial Transplant; 1992; 7(5):391-6. PubMed ID: 1321373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different erythrocyte and platelet surface electric charge in various types of glomerulonephritis.
    Klinger M; Kramarz S; Wendycz D; Kopec W
    Nephrol Dial Transplant; 1997 Apr; 12(4):707-12. PubMed ID: 9140998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis.
    Oda T; Hotta O; Taguma Y; Kitamura H; Sugai H; Onodera S; Horigome I; Suzuki K; Shouji Y; Furuta T; Chiba S; Yoshizawa N; Nagura H
    Kidney Int; 1998 May; 53(5):1190-200. PubMed ID: 9573533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.